Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1E | P49674 | 1/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.48 |
| ▸ | CNR2 | P34972 | 2/20 | 0.47 |
| ▸ | CTSK | P43235 | 5/20 | 0.44 |
| ▸ | CTSL | P07711 | 2/20 | 0.44 |
| ▸ | CTSB | P07858 | 2/20 | 0.44 |
| ▸ | CTSH | P09668 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11334152 | 0.94 | CSNK1E (0.63) | CSNK1ETRPA1CNR2 | |
| SCHEMBL28585706 | 0.94 | CSNK1E (0.63) | CSNK1ETRPA1CNR2 | |
| SCHEMBL10497252 | 0.92 | CSNK1E (0.66) | CSNK1ETRPA1CNR2 | |
| SCHEMBL10497065 | 0.92 | CSNK1E (0.66) | CSNK1ETRPA1CNR2 | |
| SCHEMBL11797062 | 0.92 | CSNK1E (0.66) | CSNK1ETRPA1CNR2 | |
| SCHEMBL10497215 | 0.92 | CSNK1E (0.66) | CSNK1ETRPA1CNR2 | |
| SCHEMBL1168932 | 0.92 | CSNK1E (0.66) | CSNK1ETRPA1CNR2 | |
| SCHEMBL10497086 | 0.92 | CSNK1E (0.66) | CSNK1ETRPA1CNR2 | |
| SCHEMBL10497048 | 0.92 | CSNK1E (0.66) | CSNK1ETRPA1CNR2 | |
| SCHEMBL10521249 | 0.92 | CSNK1E (0.66) | CSNK1ETRPA1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | claimed |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | GLYCOSCIENCE, S.L. (ES) | 2025-12-30 | — | — | US | claimed |
| CN-115427421-B | 3' -Ketoglycoside compounds for slow release of volatile alcohols | 格莱克科学有限公司 | 2025-04-01 | — | — | CN | claimed |
| US-20230183284-A1 | 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL | GLYCOSCIENCE, S.L. (ES) | 2023-06-15 | — | — | US | claimed |
| EP-4103576-A1 | 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL | Glycoscience, S.L. (ES) | 2022-12-21 | — | — | EP | claimed |
| WO-2021160670-A1 | 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL | GLYCOSCIENCE, S.L. (ES) | 2021-08-19 | — | — | WO | claimed |
| US-10590365-B2 | Compounds for a controlled release of active molecules | FIRMENICH SA (CH) | 2020-03-17 | — | — | US | claimed |
| CN-107349960-A | A kind of nitrogenous cross-linked polymer supported nanometer gold catalyst and its preparation and the application in aqueous medium in alcohol selective oxidation reaction | 中国科学院大连化学物理研究所 | 2017-11-17 | — | — | CN | claimed |
| EP-3011000-B1 | COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES | FIRMENICH & CIE (CH) | 2017-08-09 | — | — | EP | claimed |
| US-20170088793-A1 | COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES | FIRMENICH SA (CH) | 2017-03-30 | — | — | US | claimed |
| US-9550960-B2 | Compounds for a controlled release of active molecules | FIRMENICH SA (CH) | 2017-01-24 | — | — | US | claimed |
| US-20160137952-A1 | COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES | FIRMENICH SA (CH) | 2016-05-19 | — | — | US | claimed |
| EP-3011000-A1 | COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES | Firmenich SA (CH) | 2016-04-27 | — | — | EP | claimed |
| WO-2014202416-A1 | COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES | FIRMENICH SA (CH) | 2014-12-24 | — | — | WO | claimed |
| EP-2195440-A2 | BIOFUEL PRODUCTION | Bio Architecture Lab, Inc. (US) | 2010-06-16 | — | — | EP | claimed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| US-5830835-A | FABRIC SOFTENER, PERFUME ESTER MIXTURES | PROCTER & GAMBLE COMPANY (US) | 1998-11-03 | — | — | US | claimed |
| US-5668102-A | SOLID OR LIQUID COMPOSITION CONTAINING CATIONIC QUATERNARY AMMONIUM FABRIC SOFTENING COMPOUND, NONIONIC OR ANIONIC ESTER OF NON-ALLYLIC ALCOHOL PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1997-09-16 | — | — | US | claimed |
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | disclosed |
| US-3931246-A | FURYLALKYL-THIOETHERS | FIRMENICH & CIE (CH) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137952-A1 | COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES | UGT1A3, GUSB, UGT1A4 | CSNK1E 3010/4885TRPA1 1089/4885CNR2 882/4885 |
| US-20230183284-A1 | 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL | ADH1C, UGCG, ST6GAL1 | CSNK1E 3335/4885TRPA1 1683/4885CNR2 1523/4885 |
| US-10590365-B2 | Compounds for a controlled release of active molecules | UGT1A3, GUSB, UGT1A4 | CSNK1E 3010/4885TRPA1 1089/4885CNR2 882/4885 |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | EBP, MGAT1, MGAT3 | CSNK1E 3433/4885TRPA1 1897/4885CNR2 580/4885 |
| US-20170088793-A1 | COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE MOLECULES | UGT1A3, GUSB, UGT1A4 | CSNK1E 3010/4885TRPA1 1089/4885CNR2 882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.